| __timestamp | Gilead Sciences, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21102000000 | 2614539000 |
| Thursday, January 1, 2015 | 28633000000 | 3711019000 |
| Friday, January 1, 2016 | 26129000000 | 4560733000 |
| Sunday, January 1, 2017 | 21736000000 | 5475166000 |
| Monday, January 1, 2018 | 17274000000 | 6276700000 |
| Tuesday, January 1, 2019 | 17774000000 | 7081200000 |
| Wednesday, January 1, 2020 | 20117000000 | 7377200000 |
| Friday, January 1, 2021 | 20704000000 | 13634200000 |
| Saturday, January 1, 2022 | 21624000000 | 10612500000 |
| Sunday, January 1, 2023 | 20618000000 | 11301400000 |
| Monday, January 1, 2024 | 78200000 | 12231500000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of biotechnology, Gilead Sciences, Inc. and Regeneron Pharmaceuticals, Inc. have emerged as key players. Over the past decade, from 2014 to 2023, these companies have demonstrated contrasting trajectories in gross profit. Gilead Sciences, once a leader with a peak gross profit in 2015, has seen a gradual decline, with a 28% drop by 2023. In contrast, Regeneron Pharmaceuticals has experienced a remarkable growth, with its gross profit surging by over 330% during the same period. This shift highlights Regeneron's strategic advancements and market adaptability, positioning it as a formidable competitor. As the biotech industry continues to innovate, these trends underscore the dynamic nature of financial performance and the importance of strategic foresight.
Gross Profit Trends Compared: Novartis AG vs Gilead Sciences, Inc.
Gilead Sciences, Inc. or Regeneron Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Gross Profit Trends Compared: Gilead Sciences, Inc. vs Ascendis Pharma A/S
Gilead Sciences, Inc. and Catalent, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or BioMarin Pharmaceutical Inc.
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Halozyme Therapeutics, Inc.
Gilead Sciences, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Gilead Sciences, Inc. vs MiMedx Group, Inc.
Vertex Pharmaceuticals Incorporated vs Regeneron Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Regeneron Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.